Luminary Therapeutics, Inc.
- Raised $1.4 million (2025)
- 6 clinical trials, 6 active
- Research grants: $7.3 million
- Founded 2019
Life science companies
Explore 33,266 biotech, pharmaceutical, medical device, CRO and CDMO companies. Filter by type, location, clinical trials, funding, FDA registrations and research focus, then see the insights or the map. Free, and new companies are added every day.
baebies inc.
- Raised $2 million (2025)
- 2 clinical trials
- Research grants: $82 million
- Founded 2013
F-star Therapeutics, Inc.
- Raised $15 million (2016)
- 6 clinical trials
- Founded 2008
Hemoshear Therapeutics, Inc.
- Raised $3.5 million (2023)
- 2 clinical trials
- Research grants: $23 million
- Founded 2008
Kiromic Biopharma, Inc.
- Raised $135,000 (2013)
- 5 clinical trials, 1 active
- Research grants: $2.4 million
- Founded 2013
Seer, Inc.
Nasdaq: SEER
- Raised $6 million (2018)
- Research grants: $4.1 million
- Founded 2017
Spark Therapeutics, Inc.
- Raised $73 million (2014)
- 14 clinical trials, 4 active
- 1 FDA-registered drug site
- Founded 2013
Vir Biotechnology, Inc.
Nasdaq: VIR
- Raised $32 million (2020)
- 32 clinical trials, 9 active
- Founded 2016
Momentis Surgical Ltd.
- Raised $14 million (2025)
- 2 clinical trials, 1 active
- FDA-cleared or approved devices
Aclarion, Inc.
Nasdaq: ACON
- Raised $3.3 million (2018)
- 1 clinical trial, 1 active
- 1 FDA-registered device site
- Founded 2015
EpiWatch, Inc.
- Raised $190,000 (2024)
- 1 clinical trial
- FDA-cleared or approved devices
- Research grants: $551,094
Revolution Medicines, Inc.
Nasdaq: RVMD
- Raised $100 million (2019)
- 23 clinical trials, 17 active
- Founded 2014
Sensus Healthcare, Inc.
Nasdaq: SRTS
- Raised $1.4 million (2013)
- 3 clinical trials
- FDA-cleared or approved devices
- Founded 2010
Xtant Medical Holdings, Inc.
NYSE: XTNT
- Raised $5 million (2024)
- FDA-cleared or approved devices
- Founded 2006
Zetagen Therapeutics, Inc.
- Raised $13 million (2025)
- 2 clinical trials, 1 active
- Research grants: $5.6 million
- Founded 2015
Exozymes Inc.
Nasdaq: EXOZ
- Raised $11,718 (2024)
- Research grants: $6.5 million
Nektar Therapeutics
Nasdaq: NKTR
- Raised $30 million (2024)
- 54 clinical trials, 3 active
RedHill Biopharma Ltd.
Nasdaq: RDHL
- Raised $10 million (2024)
- 19 clinical trials
- Founded 2009
ClearPoint Neuro, Inc.
Nasdaq: CLPT
- Raised $18 million (2026)
- FDA-cleared or approved devices
Arena Pharmaceuticals Inc
- Raised $36 million (2010)
- 17 clinical trials
- Research grants: $106,000
Showing 360 of 33,266 companies
Load morePublished company profiles only; counts update daily. Data licences